Paracetamol Accord

Paracetamol, the active ingredient in Paracetamol Accord, is an analgesic presented as a tablet for oral use. It is used to relieve mild to moderate pain and to reduce fever in adults and children. GNH USA supplies Paracetamol Accord as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Paracetamol is an analgesic/antipyretic that acts on the central nervous system to alleviate pain and lower temperature. - Fever: reduces elevated body temperature associated with infection or inflammation. - Headache: provides relief from tension‑type and mild migraine headaches. - Musculoskeletal pain: eases discomfort from strains, sprains, and minor joint pain.

Paracetamol is generally well tolerated, but adverse reactions can occur.

Common Side Effects: - Nausea: mild stomach upset after ingestion. - Skin rash: occasional mild erythema or itching. - Elevated liver enzymes: transient increase detectable in blood tests. - Dizziness: occasional light‑headed sensation. - Sweating: mild increase in perspiration.

Serious or Rare Side Effects: - Hepatotoxicity: severe liver injury, especially with overdose or chronic high use. - Stevens‑Johnson syndrome: rare severe skin reaction. - Anaphylaxis: rare but potentially life‑threatening allergic response. - Blood dyscrasias: rare cases of agranulocytosis or thrombocytopenia.

Paracetamol should be used with attention to safety considerations. - Liver function assessment: evaluate hepatic health before prolonged use. - Alcohol consumption: avoid excessive alcohol to reduce liver risk. - Maximum daily dose: do not exceed the recommended total dose from all sources. - Renal impairment: use cautiously in patients with reduced kidney function. - Pregnancy and breastfeeding: consult a healthcare professional before use. - Store at room temperature: keep in the original pack, protect from moisture.

Paracetamol may interact with several medicines, requiring attention to avoid adverse outcomes.

Major Interactions (Avoid): - Alcohol: increases risk of liver injury. - Warfarin: may enhance anticoagulant effect, raising bleeding risk. - Carbamazepine: can reduce paracetamol plasma levels, diminishing efficacy.

Moderate Interactions (Monitor Closely): - Isoniazid: may increase hepatotoxic potential. - Phenytoin: may alter metabolism, requiring monitoring. - Rifampicin: can increase hepatic clearance of paracetamol.